Phase 1/2a clinical trial in ALS with ropinirole, a drug candidate identified by iPSC drug discovery

Overview of attention for article published in Cell Stem Cell, June 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#49 of 2,849)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

So far, Altmetric has seen 71 X posts from 69 X users, with an upper bound of 1,571,462 followers.

Clinical entry of an ALS drug discovered using pluripotent stem cell screening. Future is now my friends... https://t.co/lhJVocd1uf

RT @CellPressNews: Phase 1/2a clinical trial in ALS with ropinirole, a drug candidate identified by iPSC drug discovery https://t.co/LzGmlp…

RT @CellPressNews: Phase 1/2a clinical trial in ALS with ropinirole, a drug candidate identified by iPSC drug discovery https://t.co/LzGmlp…

Phase 1/2a clinical trial in ALS with ropinirole, a drug candidate identified by iPSC drug discovery: Cell Stem Cell https://t.co/zs5CAV78tK

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 67 additional X posts.